[Characteristics of development of oxidative stress in blood plasma of patients with familial hypercholesterolemia].
Cherniad'eva
I F
IF
Lopata
N S
NS
Muzia
G I
GI
Kulikov
V I
VI
Nasonov
E L
EL
Kukharchuk
V V
VV
D000328:Adult; D000975:Antioxidants / Q000378:metabolism; D015415:Biomarkers / Q000097:blood; D015926:Complement C3a / Q000031:analogs & derivatives / Q000378:metabolism; D015937:Complement C5a, des-Arginine / Q000378:metabolism; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood*; D018836:Inflammation Mediators / Q000097:blood; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism; D018384:Oxidative Stress; D010972:Platelet Activating Factor / Q000494:pharmacology; D013481:Superoxides / Q000378:metabolism; D014810:Vitamin E / Q000097:blood
D000975:Antioxidants; D015415:Biomarkers; D015937:Complement C5a, des-Arginine; D018836:Inflammation Mediators; D010972:Platelet Activating Factor; C044541:complement C3a, des-Arg-(77)-; D013481:Superoxides; D014810:Vitamin E; D015926:Complement C3a